RE:RE:RE:RE:RE:RE:Adlai Nortye Ltd prices offering at US$23 per share Moondance: Trust can be gained or lost by the turn of a word or phrase. Saying that ONCY's last capital raise was primarily taken up by a "large healthcare institutional buyer" as ONCY's press release alluded to, is the same as saying that Cannacord, which happens to be a large institutional buyer of healthcare company stocks, bought the deal to cover its large short position in the stock. And judging by ONCY 's current share price, the only "added shareholder value" is just an oxymoron as the only added value would seem to have flowed into Canaccord's coffers rather than to other shareholders. By all normal standards "added shareholder value" is more appropriately represented in the tangible appreciation of a company's stock price.